Vaccine Contract Manufacturing Market 2030: Trends Driving Growth
Global Vaccine Contract Manufacturing Market Overview The global vaccine contract manufacturing market was valued at USD 2.14 billion in 2023 and is projected to reach USD 3.60 billion by 2030, growing at a CAGR of 7.8% from 2024 to 2030. This growth is primarily fueled by the increasing global demand for vaccines and the rising trend of outsourcing manufacturing processes to contract manufacturing organizations (CMOs). Beyond the focus on vaccine safety and efficacy, the volume of vaccine development annually is a key consideration for manufacturing scalability. With more countries requesting the introduction of new vaccines to address public health needs, the pharmaceutical industry is required to scale up its capacity to meet the growing demands across diverse population groups and age ranges. The expansion of vaccination programs and continuous innovation in vaccine research are high-impact growth drivers. An increasing number of vaccine candidates entering clinical development...